| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $368.9M | +9.7% |
| Gross Profit | $139.8M | +13.4% |
| R&D Expense | $4.4M | +18.9% |
| SG&A Expense | $111.9M | +21.9% |
| Operating Income | -$12.8M | -70.7% |
| Pre-tax Income | -$23.7M | +24.3% |
| Income Tax | -$2.2M | +47.6% |
| Net Income | -$21.5M | +20.7% |
| EPS (Basic) | -$0.26 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $76.1M | +22.7% |
| Accounts Receivable | $43.9M | +38.9% |
| Inventory | $21.7M | +25.4% |
| Current Assets | $151.2M | +21.1% |
| Total Assets | $1.10B | -1.6% |
| Current Liabilities | $68.4M | +42.5% |
| Long-term Debt | $406.4M | +1.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $41.4M | -21.3% |
| Investing Cash Flow | -$32.5M | +38.0% |
| Financing Cash Flow | $1.8M | +200.0% |
| +21.2% |
| EPS (Diluted) | -$0.26 | +21.2% |
| Total Liabilities |
| $556.1M |
| +1.0% |
| Stockholders' Equity | $548.1M | -4.2% |